Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 3, 2006, Pages

  Redon, Josep ^a,b   Morales Olivas, Francisco ^b   Galgo, Alberto ^c   Brito, Miguel Ángel ^d   Mediavilla, Javier ^e   Marín, Rafael ^f   Rodríguez, Pilar ^g   Tranche, Salvador ^h   Lozano, José Vicente ⁱ   Filozof, Claudia ^j  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Centro de Salud Espronceda   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e Servicio de Medicina Familiar   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g Fingoi Health Centre   (Spain)

^h El Cristo Health Centre   (Spain)

ⁱ Centro de Salud Nazaret   (Spain)

^j BRISTOL MYERS SQUIBB   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; URINALYSIS; URINARY EXCRETION;

EID: 33845234269     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080920     Document Type: Conference Paper

References (35)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310: 356-360, 1984
2. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 2: 530-533, 1988
3. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300: 297-300, 1990
4. Haffner SM, Stern MP, Kozlowski MK, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria. Potential marker for increased cardiovascular factors in non-diabetic subjects? Atherosclerosis 10: 727-731, 1990
5. Bigazzi R, Bianchi S, Baldari D, Campese VM: Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16: 1325-1333, 1998
6. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992-1997, 1999
7. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19: 617-624, 1999
8. Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, de Jong PE, de Zeeuw D, van Der Schouw YT: Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103: 3057-3061, 2001
9. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426, 2001
10. Romunstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H: Microalbuminuria and all-cause mortality in treated hypertensive individuals. Does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 108: 2783-2789, 2003
11. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, De Faire U, Fyhrquist F, Julkius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Ann Intern Med 139: 901-906, 2003
12. Atkins RC, Briganti EM, Zimmet PZ, Chadban SJ: Association between albuminuria and proteinuria in the general population: The AusDiab Study. Nephrol Dial Transplant 18: 2170-2174, 2003
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003
14. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
15. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191-1200, 2001
16. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562, 2002
17. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 137: 563-570, 2002
18. Sorensen CR, Brendorp B, Rask-Madsen C, Kober L, Kjoller E, Torp-Pedersen C: The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 23: 948-952, 2002
19. Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D; CATS Randomized Trial: Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: The CATS randomized trial. Eur Heart J 24: 412-420, 2003
20. Anavekar NS, McMurray JJV, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004
21. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35: 681-689, 2000
22. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med 351: 1296-1306, 2004
23. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140: 167-174, 2004
24. Marín R, de la Sierra A, Armario P, Banegas JR, Campo C, Gorostidi M: 2005 Spanish guidelines in diagnosis and treatment of arterial hypertension [in Spanish]. Med Clin 125: 24-34, 2005
25. Kidney Disease Outcome Quality Initiative: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39[Suppl 2]: S1-S246, 2002
26. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; for the DEMAND Investigators: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int 69: 2057-2063, 2006
27. Kalter-Leibovici O, Van Dyk DJ, Leibovici L, Loya N, Erman A, Kremer I, Boner G, Rosenfeld JB, Karp M, Laron Z: Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes 40: 204-210, 1991
28. Redon J, Pascual JM: Development of microalbuminuria in essential hypertension. Curr Hypertens Rep 8: 171-177, 2006
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
30. Hallan S, Asberg A, Lindberg M, Johnsen H: Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 44: 84-93, 2004
31. Rule AR, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141: 929-937, 2004
32. Clase CM, Garg AX, Kiberd B: Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol 13: 2812-2816, 2002
33. Viktorsdottir O, Palsson R, Andresdottir MB, Aspeland T, Gudnason V, Indridason OS: Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 20: 1799-1807, 2005
34. Redon J, Cea-Calvo L, Lozano JV, Fernandez-Perez C, Navarro J, Bonet A, Gonzalez-Esteban J; Investigators of the ERIC-HTA 2003 Study: Kidney function and cardiovascular disease in the hypertensive population: The ERIC-HTA study. J Hypertens 24: 663-669, 2006
35. Ruilope LM, Alcazar JM, Hernandez E, Rodicio JL: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 45: S171-S173, 1994